Home Law \ Legal Cyril Amarchand Mangaldas advises sellers on INR 9,500 crore acquisition by Advent

Cyril Amarchand Mangaldas advises sellers on INR 9,500 crore acquisition by Advent

2 min read
Comments Off on Cyril Amarchand Mangaldas advises sellers on INR 9,500 crore acquisition by Advent
0
20


Cyril Amarchand Mangaldas advised the promoters of Suven Pharmaceuticals Limited (Suven Pharmaceuticals) in relation to the acquisition of Suven Pharmaceuticals by global private equity firm Advent, for an aggregate amount of INR 9,500 crore (approx.) through a share purchase agreement for c. 51% followed by an open offer for 26%.

The General Corporate and Competition Law Practices of Cyril Amarchand Mangaldas acted as the legal counsel for promoters of Suven Pharmaceuticals on the transaction. The scope of work included undertaking vendor due diligence exercise, carrying out drafting, negotiations, review and finalisation of the share purchase agreement and ancillary agreements. The transaction team was led by Shishir Vayttaden, Partner; with support from Reeti AgarwalAssociate; Raksha Raina, Associate; Kashish Mahajan, Associate; Saumya Sharma, Associate; and Tawishi BeriaAssociateBhargav Joshi, Partner assisted with the due diligence exercise.

The Real Estate team was led by Namrata KolarPartner (Co-head-Real Estate); with support from Jaideep Kodali, Principal Associate.

Pharma and Life Sciences team was led by Biplab LeninPartner; with support from Kartik Jain, Senior Associate.

Avaantika KakkarPartner (Head-Competition Law); advised on the competition law related aspects of the transaction.

As a part of the Transaction, Advent, has agreed to buy out a majority in Suven Pharmaceuticals Limited from our clients. Advent will also make an open offer to acquire 26% shares from public shareholders.

Other Parties and Advisors to the transaction included Barclays (acted as banker for the sellers).

The transaction was signed on 26th December 2022.





Source link

Load More Related Articles
Load More By 
Load More In Law \ Legal
Comments are closed.

Check Also

Competition Bureau ends fight to block Rogers-Shaw merger [Jan 21-27]

The Competition Bureau will no longer appeal against the Rogers-Shaw merger and Vidéotron’…